IP Library Granted Patent US 8,771,256
Granted Patent B2
US 8,771,256 · App. 12/913,065 · Granted Jul 8, 2014

Device delivering medicines by transpalpebral electrophoresis

Inventors: Francine Behar-Cohen (Paris, FR); Pierre Roy (Paris, FR)
Assignee: Eyegate Pharma S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,256
App. No.
12/913,065
Granted
Jul 8, 2014
Kind
B2
Abstract

The invention concerns a device for ocular application of an active principle ( 1 ) comprising a main electrode ( 2 ) including an insulating layer, an adhesive layer designed to bind the insulating layer to a conductive layer, characterized in that the main electrode comprises a zone ( 21, 22 ) designed to be urged into contact with an eyelid.

Claims (7)

1. A method for ocular application of an active substance through iontophoresis, the method comprising:

disposing a main electrode on an eyelid of a patient;

disposing a return electrode on a tissue of the patient away from the eyelid;

disposing an insert between the eyelid and the eyeball, the insert comprising the active substance and being disposed between the main electrode and the eyeball; and

substantially closing the eyelid and applying an electrical current circulating between the main electrode and the return electrode thereby allowing the active substance to penetrate the sclera of an eyeball of the patient via the applied electrical current, wherein the active substance penetrates into the eyeball via iontophoresis.

2. A method according to claim 1 , wherein the electrical current is a direct current (DC) having an amplitude between about 0.5 mA and about 10 mA.

3. A method according to claim 1 , further comprising impregnating an absorbent foam layer within the main electrode with the active substance.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2011
From: BEHAR-COHEN, FRANCINE
To: OPTIS FRANCE S.A.
Reel/Frame 027228/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2011
From: ROY, PIERRE
To: OPTIS FRANCE S.A.
Reel/Frame 027057/0231 →
CHANGE OF NAME Recorded Oct 13, 2011
From: OPTIS FRANCE S.A.
To: EYEGATE PHARMA S.A.
Reel/Frame 027057/0247 →
CHANGE OF LEGAL ENTITY Recorded Oct 13, 2011
From: EYEGATE PHARMA S.A.
To: EYEGATE PHARMA S.A.S.
Reel/Frame 027059/0928 →
Priority Claims (1)
FR 01 13176 · Oct 12, 2001 · national
Continuity (2)
Continuation 10492494
Related Publication 20110098632A1 · Apr 28, 2011